The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src

Molecular and Cellular Biochemistry

Volumn 175, Issue 1-2, 1997, Pages 243-252

  Guappone, Anne C ^a   Flynn, Daniel C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Actin; SH2; SH3; Src; Stable complex

Indexed keywords

PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; TYROSINE;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; COMPLEX FORMATION; CONTROLLED STUDY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; STEADY STATE;

AMINO ACID SUBSTITUTION; ANIMALS; BLOTTING, WESTERN; CLONING, MOLECULAR; COS CELLS; GLUTATHIONE TRANSFERASE; MICROFILAMENT PROTEINS; MUTAGENESIS; PHOSPHOPROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS; SUBSTRATE SPECIFICITY; TYROSINE;

ANIMALIA;

EID: 0030712930     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006840104666     Document Type: Article

References (49)

1. Cooper JA, Brown MT: Regulation, substrates and functions of src. Biochim Biophys Acta Gene Struct Exper 1287: 121-149, 1996
2. Barnekow A, Paul E, Schartl M: Expression of the c-src protooncogene in human skin tumors. Cancer Res 47: 235-240, 1987
3. c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84: 2251-2255, 1987
4. c-src activation in human colon carcinoma. J Clin Invest 83: 2025-2033, 1989
5. c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87: 558-562, 1990
6. c-src protein kinase in adult and fetal human tissues: High activities in some sarcomas and mammary carcinomas. Cancer Res 43: 1696-1702, 1983
7. c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261: 13754-13759, 1986
8. Schaller MD, Bouton AH, Flynn DC, Parsons JT: In: WE Cohn, K Moldave (eds). Progress in Nucleic Acid Research and Molecular Biology. Academic Press Inc., San Diego, CA, 1993 44: 205-227
9. Pawson T: Protein modules and signalling networks. Nature 373: 573-580, 1995
10. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanatusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778, 1993
11. Ren R, Mayer BJ, Cicchetti P, Baltimore D: Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161, 1993
12. Yu H, Rosen MK, Shin TB, Seidel-Dugan C, Brugge JS, Schreiber SL: Solution structure of the SH3 domain of Src and Identification of its ligand-binding site. Science 258: 1665-1670, 1993
13. Lemmon MA, Ladbury JE, Mandiyan V, Zhou M, Schlessinger J: Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. J Biol Chem 269: 31653-31658, 1994
14. src substrate. Mol Cell Biol 13: 7892-7900, 1993
15. Brott BK, Decker S, O'Brien MC, Jove R: Molecular features of the viral and cellular Src kinases involved in interactions with the GTPase-activating protein. Mol Cell Biol 11: 5059-5067, 1991
16. Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA: A target for Src in mitosis. Nature 368: 871-874, 1994
17. Taylor SJ, Shalloway D: An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 368: 867-871, 1994
18. Fak-binding region. J Cell Sci 107: 1583-1591, 1993
19. FAK Mol Cell Biol 14: 147-155, 1994
20. src. Mol Cell Biol 14: 1680-1688, 1994
21. src direct stable association with tyrosine phosphorylated proteins p130 and p110. EMBO J 10: 1689-1698, 1991
22. src with two tyrosine phosphorylated cellular proteins. Mol Cell Biol 9: 3951-3958, 1989
23. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H: A novel signalling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 13: 3748-3756, 1994
24. Weng A, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Dreyfuss G, Brugge JS: Identification of Src, Fyn, and Lyn SH3-binding proteins: Implications for a function of SH3 domains. Mol Cell Biol 14: 4509-4521, 1994
25. Weng Z, Rickles RJ, Feng S, Richard S, Shaw AS, Schrieiber SL, Brugge JS: Structure function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol 15: 5627-5634, 1995
26. Liu X, Marengere LE, Koch CA, Pawson T: The v-Src SH3 domain binds phosphatidylinositol 3′-kinase. Mol Cell Biol 13: 5225-5232, 1993
27. Prasad KV, Kapeller R, Janssen O, Repke H, Duke-Cohan JS, Cantley LC, Rudd CE: Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p561ck complex: The p561ck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol Cell Biol 13: 7708-7717, 1993
28. Vogel LB, Fujita DJ: The SH3 domain of p561ck is involved in binding to phosphatidylinositol 3′-kinase from T lymphocytes. Mol Cell Biol 13: 7408-7417, 1993
29. v-src and alter cellular morphology. J Virol 66: 1866-1874, 1992
30. Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW, Campbell ID, Waterfield MD: The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75: 25-36, 1993
31. Okada M, Howel BW, Broome MA, Cooper JA: Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxy 1-terminal tyrosine. J Biol Chem 258: 18070-18075, 1993
32. c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res 3: 343-355, 1988
33. Seidel-Dugan C, Meyer BE, Thomas SM, Brugge JS: Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol Cell Biol 12: 1835-1845, 1992
34. Superti-Furga G, Fumafalli S, Doegl M, Courtneidge SA, Draaetta G: Csk inhibition of c-Src activity requires both the SH2 and SH3 domains. EMBO J 12: 2625-2634, 1993
35. fyn. Mol Cell Biol 14: 6372-6385, 1994
36. Flynn DC, Koay TC, Humphries CG, Guappone AC: AFAP-120: A variant form of the Src SH2/SH3 binding partner AFAP-110 is detected in brain and contains a novel internal sequence which binds to a 67 kDa protein. J Biol Chem 270: 3894-3899, 1995
37. Bar-Sagi D, Rotin D, Batzer A, Mandiyan V, Schlessinger J: SH3 domains direct cellular localization of signalling molecules. Cell 74: 83-91, 1993
38. v-src association with the cytoskeleton induces actin reorganization without affecting polymerization status. Eur J Cell Biol 52: 4759, 1990
39. Reynolds AB, Roesel DJ, Kanner SB, Parsons JT: Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular Src gene. Mol Cell Biol 9: 629-638, 1989
40. Guappone AC, Qian Y, Weimer TG, Flynn DC: An in vivo system for analysis of stable complex formation between Src and AFAP-110. Meth Cell Sci 18: 1-11, 1996
41. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752, 1987
42. c-src+. Oncogene 7: 579-583, 1992
43. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with gultathione S-transferase. Gene 67: 31-40, 1988
44. src of avian and mammalian origin. J Virol 51: 272-282, 1984
45. Cheadle C, Ivashchenko Y, South V, Searfoss GH, French S, Howk R, Ricca GA, Jaye M: Identification of a Src SH3 domain binding motif by screening a random phage display library. J Biol Chem 269: 24034-24039, 1994
46. Rickles RJ, Botfield MC, Weng Z, Taylor JA, Green OM, Brugge JS, Zoller MJ: Identification of Src, Fyn, Lyn, PI3-K and Abl SH3 domain ligands using phage display libraries. EMBO J 13: 5598-5604, 1994
47. Rickles RJ, Botfield MC, Zhou X-M, Henry PA, Brugge JS, Zoller MJ: Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci USA 92: 10909-10913, 1995
48. Sparks AB, Quilliam LA, Thorn JM, Der CJ, Kay BK: Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J Biol Chem 269: 23853-23856, 1994
49. src with Triton X-100-resistant cellular structure correlates with morphological transformation. Proc Natl Acad Sci USA 84: 2312-2316, 1987